Rcadia Medical Solutions

What Rcadia Medical Solutions does

Rcadia Medical Solutions Ltd. is a privately-held medical technology company that develops and markets the COR Analyzer System, an FDA 510(k)-cleared medical device designed to perform fully automated analysis of Coronary CT Angiography (cCTA) studies. The system uses proprietary, patent-pending image processing algorithms to isolate the heart region, reconstruct the coronary tree, detect significant stenotic lesions, and generate curved multi-planar reformation (MPR) visualizations and automated reports without requiring human interaction during analysis. It is compatible with all major 64-slice and higher CT scanners from GE, Siemens, Philips, and Toshiba, and exports results to hospital PACS systems.

The company's primary customers are U.S. hospital emergency departments, radiology departments, and cardiology departments that need rapid triage of chest pain patients, workflow prioritization, and second-reader sensitivity enhancement for cCTA interpretation. Named reference deployments include Baptist Hospital of Miami and Galichia Heart Hospital. The company monetizes through direct enterprise sales of the COR Analyzer system as an FDA-cleared medical device, with marketing efforts focused on clinical validation publications, scientific symposia (e.g., SCCT), case studies, and product brochures.

Rcadia is headquartered in Wellesley, Massachusetts under the legal entity Rcadia Medical Solutions Ltd., with disclosed Israeli ties through its R&D leadership (CTO background at Technion, IBM Haifa, RAFAEL). Leadership consists of Peter Feinstein (Chairman, also General Partner and co-founder of BioVentures Investors), Vitaly Sirota (CEO, serial entrepreneur), and Dr. Roman Goldenberg (VP R&D and CTO). The firm has 1-10 employees, a single product line, no publicly disclosed funding rounds or revenue, and an active website dated 2023 indicating ongoing operations.

Name

Rcadia Medical Solutions

Legal name

Rcadia Medical Solutions Ltd.

Website

https://rcadia.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Rcadia Medical Solutions develops and markets the FDA-cleared COR Analyzer System, which performs fully automated analysis of Coronary CT Angiography studies to detect coronary artery stenosis for U.S. hospital emergency, radiology, and cardiology departments.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Diagnostic & Triage Decision Support (HLACAGAA)

akta.pro secondary industries

Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI), Radiology Reporting, Dictation & Structured Reporting (HLACALAF)

Keywords

• Medical imaging software
• Cardiac CT analysis
• Coronary angiography
• Clinical decision support
• CAD detection

Headquarters

HQ city

Wellesley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. COR Analyzer System Sales: Sale of FDA-cleared medical device systems (COR Analyzer) to hospitals and healthcare institutions. The company develops and markets proprietary systems for computerized medical image analysis, with the COR Analyzer performing automated cCTA analysis for coronary artery disease detection.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Rcadia Medical Solutions develops and markets the FDA-cleared COR Analyzer System, which performs fully automated analysis of Coronary CT Angiography (cCTA) studies to identify significant stenotic lesions in coronary arteries. The system serves as a clinical decision support tool for emergency departments, radiology departments, and cardiology departments to triage chest pain patients and enhance clinical workflow.

Product overview

Rcadia Medical Solutions offers a single unified FDA-cleared medical device product: the COR Analyzer System. This system provides fully automated Coronary CT Angiography (cCTA) analysis for identifying significant coronary artery stenosis. The product operates as a standalone analysis system that integrates with CT scanners and PACS systems, providing automated workflow processing from image acquisition through report generation.

Differentiator

Problem solved

Functional benefit

Brands

• COR Analyzer System: FDA-cleared system that performs fully automated analysis of Coronary CT Angiography (cCTA) studies to identify significant stenotic lesions in coronary arteries and provide immediate indication of patients suspected of coronary artery disease.

Products and services

• COR Analyzer System FDA-cleared medical device software that performs fully automated analysis of Coronary CT Angiography (cCTA) studies to identify significant stenotic lesions in coronary arteries. Designed for use in hospital emergency departments, radiology departments, and cardiology departments to triage chest pain patients, provide rapid clinical decision support, and enhance clinical workflow through automated patient prioritization and second-reader sensitivity.

Quantifiable outcome

• Reduce time to treatment in emergency department settings
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature7 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Emerging players

• Viz.ai: Viz.ai is an AI-powered care coordination and imaging workflow company that originated in stroke triage and is expanding into cardiac and other time-sensitive pathways analogous to Rcadia's ED use case.
• Arterys: Arterys delivers cloud-based AI medical imaging platforms across cardiac, lung, and other modalities, competing for the same hospital AI imaging workflow slot as Rcadia's COR Analyzer.
• Zebra Medical Vision (Nanox): Zebra Medical Vision, now part of Nanox, provides AI algorithms for radiology including cardiac CT applications, positioning it as an adjacent AI imaging competitor in hospital deployments.

Direct peers

• Circle Cardiovascular Imaging: Circle CVI provides post-processing and analysis software for cardiac CT and MR imaging used in hospital cardiology and radiology departments, overlapping with COR Analyzer's clinical workflow.
• Cleerly Health: Cleerly applies AI to coronary CTA for plaque and stenosis quantification, directly competing with Rcadia's automated cCTA analysis in cardiology and radiology hospital workflows.
• HeartFlow: HeartFlow's FFR-CT Analysis is a direct competitor to the COR Analyzer, providing non-invasive, AI-enabled analysis of coronary CT angiography to assess coronary artery disease in hospital settings.
• Elucid Bioimaging: Elucid develops AI software for cardiovascular imaging analysis from CT, targeting atherosclerotic plaque and stenosis characterization directly comparable to Rcadia's cCTA analysis capabilities.

Broad incumbents

• TeraRecon (ConcertAI): TeraRecon offers advanced visualization and AI-driven analysis for cardiac and other imaging modalities, serving hospital radiology and cardiology departments with overlapping cCTA post-processing capabilities.
• RapidAI: RapidAI provides AI-driven imaging workflow and clinical decision support across neuro, cardiac, and vascular indications, overlapping with Rcadia's cardiac triage and second-reader use cases.
• Aidoc: Aidoc is a broader AI imaging platform used across hospital radiology workflows; its cardiac and triage algorithms place it as an overlapping incumbent in ED imaging decision support.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rcadia Medical Solutions